HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $275,000 | +51.1% | 65,136 | -0.4% | 0.10% | +56.9% |
| Q2 2022 | $182,000 | -54.4% | 65,389 | -6.3% | 0.06% | -45.4% |
| Q1 2022 | $399,000 | -5.0% | 69,759 | +51.6% | 0.12% | +1.7% |
| Q4 2021 | $420,000 | -23.4% | 46,023 | -10.2% | 0.12% | -32.0% |
| Q3 2021 | $548,000 | -31.1% | 51,247 | 0.0% | 0.17% | -26.2% |
| Q2 2021 | $795,000 | -4.3% | 51,247 | -0.0% | 0.23% | -9.7% |
| Q1 2021 | $831,000 | -23.2% | 51,270 | +0.3% | 0.26% | -32.6% |
| Q4 2020 | $1,082,000 | +57.0% | 51,115 | +9.9% | 0.38% | +33.0% |
| Q3 2020 | $689,000 | +1.2% | 46,490 | +0.4% | 0.29% | +1.4% |
| Q2 2020 | $681,000 | +24.7% | 46,318 | -0.5% | 0.28% | +4.4% |
| Q1 2020 | $546,000 | -49.3% | 46,535 | +1.5% | 0.27% | -40.5% |
| Q4 2019 | $1,077,000 | +27.6% | 45,846 | +0.5% | 0.46% | +22.2% |
| Q3 2019 | $844,000 | -0.4% | 45,635 | +0.1% | 0.37% | +2.7% |
| Q2 2019 | $847,000 | -23.2% | 45,567 | +1.0% | 0.36% | -24.2% |
| Q1 2019 | $1,103,000 | – | 45,131 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |